Clinical Trial: A Prospective Real-World Observational Study of Nanocrystalline Megestrol Acetate in Patients With Cancer Cachexia

U.S., Nov. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07243379) titled 'A Prospective Real-World Observational Study of Nanocrystalline Megestrol Acetate in Patients With Cancer Cachexia' on Nov. 15.

Brief Summary: This study is a prospective, real-world observational study. The objective is to evaluate the effectiveness and safety of nanocrystalline megestrol acetate in patients with cancer cachexia in real-world settings. Eligible participants were patients diagnosed with cancer cachexia who were scheduled to receive treatment with nanocrystalline megestrol acetate.

Study Start Date: Sept. 25

Study Type: INTERVENTIONAL

Condition: Clinical Characteristics and Treatment Outcomes of Malignant Tumor C...